424B5The Raise
Enliven Therapeutics, Inc. files 424B5
Filed Mar 15, 2022 · 4y ago · Accession 0001193125-22-076183
Plain English
424B5 filed with the SEC.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 424B5
- Filing date
- Mar 15, 2022
- Report date
- —
- Document
- d321483d424b5.htm
- Size
- 104 KB